Lotus Pharm vs Taiwan Biomaterial: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Taiwan Biomaterial (6649) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Taiwan Biomaterial

0%+226%-78%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYTaiwan BiomaterialYoY
Oct 2026NT$2.13 billion-22.5%NT$12.4 million-34.1%
Sep 2026NT$2.77 billion+128.0%NT$17 million-49.3%
Aug 2026NT$2.11 billion+81.7%NT$14.4 million-32.8%
Jul 2026NT$2.49 billion+3.9%NT$12.4 million-30.3%
Jun 2026NT$3.4 billion+225.5%NT$13.1 million+16.5%
May 2026NT$2.32 billion+105.8%NT$12.3 million-9.9%
Apr 2026NT$3.09 billion+19.9%NT$11.5 million+29.9%
Mar 2026NT$4.35 billion+173.6%NT$11.5 million-38.2%
Feb 2026NT$2.24 billion+131.5%NT$7.2 million-78.3%
Jan 2026NT$2.05 billion-5.5%NT$7.7 million-51.5%
Dec 2025NT$2.44 billion+66.9%NT$16.9 million+61.5%
Nov 2025NT$1.06 billion-0.2%NT$10.6 million+18.8%
Oct 2025NT$2.75 billion+46.0%NT$18.8 million+93.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16